cervical spondylosis
Conditions
Interventions
treatment group:Pi zheng particles
control group I:Jin Kang Fu particle
control group II:Placebo of Pi zheng particles
Sponsors
Long Hua Hospital Shanghai University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: (1) patients who met the diagnostic criteria and TCM syndrome criteria; (2) patients who voluntarily accepted the treatment in this study; (3) Aged between 18~65 years old; (4) signed informed consent.;Inclusion criteria: (1) patients who met the diagnostic criteria and TCM syndrome criteria; (2) patients who voluntarily accepted the treatment in this study; (3) Aged between 18~65 years old; (4) signed informed consent.;Inclusion criteria: (1) patients who met the diagnostic criteria and TCM syndrome criteria; (2) patients who voluntarily accepted the treatment in this study; (3) Aged between 18~65 years old; (4) signed informed consent.;Inclusion criteria: (1) patients who met the diagnostic criteria and TCM syndrome criteria; (2) patients who voluntarily accepted the treatment in this study; (3) Aged between 18~65 years old; (4) signed informed consent.;Inclusion criteria: (1) patients who met the diagnostic criteria and TCM syndrome criteria; (2) patients who voluntarily accepted the treatment in this study; (3) Aged between 18~65 years old; (4) signed informed consent.
Exclusion criteria
Exclusion criteria: 1. refuse treatment and randomized grouping; 2. combined with cardiovascular disease, mental illness, suspected alcohol and drug abuse; 3. with image evidence of bone fracture or other bone disease; 4. intensive pain, with spinal cord compression and surgical indications; 5. receiving other treatment,witch may affect the observation of indexes for therapeutic effects in this study; 6. have skin diseases and infectious diseases; 7. allergic to "Methycobal" and "Jingfukang Granule "or the drug ingredients; 8. female patients who are pregnant; 9. cannot take treatment in other reasons.;Exclusion criteria: 1. refuse treatment and randomized grouping; 2. combined with cardiovascular disease, mental illness, suspected alcohol and drug abuse; 3. with image evidence of bone fracture or other bone disease; 4. intensive pain, with spinal cord compression and surgical indications; 5. receiving other treatment,witch may affect the observation of indexes for therapeutic effects in this study; 6. have skin diseases and infectious diseases; 7. allergic to "Methycobal" and "Jingfukang Granule "or the drug ingredients; 8. female patients who are pregnant; 9. cannot take treatment in other reasons.;Exclusion criteria: 1. refuse treatment and randomized grouping; 2. combined with cardiovascular disease, mental illness, suspected alcohol and drug abuse; 3. with image evidence of bone fracture or other bone disease; 4. intensive pain, with spinal cord compression and surgical indications; 5. receiving other treatment,witch may affect the observation of indexes for therapeutic effects in this study; 6. have skin diseases and infectious diseases; 7. allergic to "Methycobal" and "Jingfukang Granule "or the drug ingredients; 8. female patients who are pregnant; 9. cannot take treatment in other reasons.;Exclusion criteria: 1. refuse treatment and randomized grouping; 2. combined with cardiovascular disease, mental illness, suspected alcohol and drug abuse; 3. with image evidence of bone fracture or other bone disease; 4. intensive pain, with spinal cord compression and surgical indications; 5. receiving other treatment,witch may affect the observation of indexes for therapeutic effects in this study; 6. have skin diseases and infectious diseases; 7. allergic to "Methycobal" and "Jingfukang Granule "or the drug ingredients; 8. female patients who are pregnant; 9. cannot take treatment in other reasons.;Exclusion criteria: 1. refuse treatment and randomized grouping; 2. combined with cardiovascular disease, mental illness, suspected alcohol and drug abuse; 3. with image evidence of bone fracture or other bone disease; 4. intensive pain, with spinal cord compression and surgical indications; 5. receiving other treatment,witch may affect the observation of indexes for therapeutic effects in this study; 6. have skin diseases and infectious diseases; 7. allergic to "Methycobal" and "Jingfukang Granule "or the drug ingredients; 8. female patients who are pregnant; 9. cannot take treatment in other reasons.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| VAS;DHI;JOA score; | — |
Countries
China
Contacts
Public ContactWen Mo;Wen Mo;Wen Mo;Wen Mo;Wen Mo ;;;;
Long Hua Hospital Shanghai University of Traditional Chinese Medicine;Long Hua Hospital Shanghai University of Traditional Chinese Medicine;Long Hua Hospital Shanghai University of Traditional Chinese Medicine;Long Hua Hospital Shanghai University of Traditional Chinese Medicine;Long Hua Hospital Shanghai University of Traditional Chinese Medicine
Outcome results
None listed